Abstract:Abstract Background and Aims At present, the clinical burden and treatment pattern of hyperkalaemia among outpatients in China is not well characterized. The aim of this study was to evaluate the disease distribution and treatment pattern of hyperkalaemia among outpatients in China. Method Data were derived from Beijing Data Center for Rational Use of Drugs, which contains primary records of 157 hospitals, covering 30 provinces in China. Patients who accessed outpatients (aged >=≥18 years old) with record(s) of serum potassium (S-K) between 2015.1.1- 2017.12.31 were included. The laboratory test, diagnoses, and treatments were analyzed. Hyperkalaemia defined as S-K > 5.0 mmol/L. A hyperkalaemia episode was defined as one or more consecutive S-K > 5.0mmol/L measurement(s) within 7 days. If there was a return to S-K <5.0mmol/L within 7 days, the subsequent measurement(s) will be recognized as another hyperkalaemia episode. The proportion of hyperkalaemia was defined as the proportion of patients who experienced at least one hyperkalaemia episode. The main outcomes, including the proportion of hyperkalaemia patients, the diagnosis rate, the treatment rate and the S-K retesting rate were analyzed. The geographic and seasonal distribution of the proportion was examined. The diagnosis rate was defined as the proportion of hyperkalaemia episodes that have diagnoses records of hyperkalaemia within the episode. Treatment rate was defined as the proportion of hyperkalaemia episodes that have records of any hyperkalaemia treatment including diuretics, glucose injection + insulin, calcium injection, sodium bicarbonate, potassium binder, transfer to emergency room or dialysis. Retesting rate was defined as the proportion of hyperkalaemia records that have potassium test record(s) within one day, two days or seven days. Results A total of 2,997,634 patients with at least one S-K record each were analysed. 115,826 patient (3.86%) experienced hyperkalaemia (S-K >5.0mmol/L), in which 28,254 patients (0.94%), experienced S-K ≥5.5mmol/L. In patients with chronic kidney disease, heart failure, hypertension, and diabetes mellitus, the proportions of patients who experienced hyperkalaemia were 22.89%, 12.54%, 7.11% and 6.51%, respectively. Composition proportion of who experienced S-K ≥ 5.5mmol/L, in the patients with CKD and HF, defined as the proportion of patients experienced S-K≥ 5.5mmol/L in all hyperkalaemia patients, were 39.27% and 32.16% respectively, higher than the general population (16.3%). Geographic analysis showed that provinces with higher proportions of hyperkalaemia were Jiangsu (9.22%), Hebei (8.31%), Tianjin (6.74%), Hunan (6.27%) and Liaoning (5.56%). In addition, the seasonal proportion varied as winter (4.18%), autumn (3.93%), spring (3.83%) and summer (3.57%). In patients with hyperkalaemia, the overall hyperkalaemia diagnosed rate within the episode was 2.53%. Diagnosed rates increased by the severity of hyperkalaemia, patients with S-K ≥7.0 mmol/L showed the highest diagnosed rate of 9.63%. The overall hyperkalaemia treated rate was 8.69%. The treated rate of patients with S-K 5.0 to 5.5mmol/L was much lower than that of patients with S-K 5.5 -6.0mmol/L (6.6% vs. 12.01%). The overall retesting rate within 7 days was 11.41%. Patients with S-K 5.0-5.5 mmol/L were retested less frequently (8.51%) than those with S-K ≥5.5 mmol/L (15.56-21.76%). Conclusion The proportions of hyperkalaemia in patients with chronic kidney disease, heart failure, hypertension and diabetes were higher than the proportion in overall outpatients. The severity of hyperkalaemia increased in patients with chronic kidney disease and heart failure. The diagnosed rate, treated rate and resting rate of hyperkalaemia in outpatients were low, showing a slight raise with increased severity.

The Impact of Hyperkalemia on Mortality and Healthcare Resource Utilization Among Patients With Chronic Kidney Disease: A Matched Cohort Study in China

[The Prevalence, Influencing Factors and Prognosis of Abnormal Serum Potassium Levels in Patients with Chronic Kidney Disease].

Hyperkalemia and risk of chronic kidney disease progression: A propensity score matched analysis

The Effect of Chronic Kidney Disease on the Long-Term Prognosis of Patients with Left Main Coronary Artery Disease after Revascularization

Postdischarge Health Care Costs and Readmission in Patients with Hyperkalemia-Related Hospitalizations

Economic burden of recurrent hyperkalemia in patients with chronic kidney disease

P0799EPIDEMIOLOGY AND TREATMENT PATTERN OF HYPERKALAEMIA AMONG OUTPATIENTS IN CHINA: A DESCRIPTIVE STUDY USING AN ADMINISTRATIVE DATABASE IN CHINA

The burden of hyperkalaemia on hospital healthcare resources

Hyperkalemia Incidence in Patients With Non-Dialysis Chronic Kidney Disease: A Large Retrospective Cohort Study From United States Clinical Care

[Current Status of Hyperkalemia in Dialysis Patients in China].

The impact of hyperkalemia on ICU admission and mortality: a retrospective study of Chinese emergency department data

Hyperkalaemia prevalence and dialysis patterns in Chinese patients on haemodialysis: an interim analysis of a prospective cohort study (PRECEDE-K)

Healthcare Resource Utilisation for Chronic Kidney Disease and Other Major Non-Communicable Chronic Diseases in China: a Cross-Sectional Study

Effects of hyperkalemia on the prognosis of patients with acute myocardial infarction

Clinical Outcomes by Serum Potassium Levels for Patients Hospitalized for Heart Failure: Secondary Analysis of Data from the China National Heart Failure Registry.

Impact of Initial Dialysis Modality on the Survival of Patients with ESRD in Eastern China: a Propensity-Matched Study.

Pre‐ to post‐dialysis potassium gradient and mortality in patients on hemodialysis: A propensity‐matched analysis

Hyperkalemia burden and treatment patterns in Chinese patients on hemodialysis: final analysis of a prospective multicenter cohort study (PRECEDE-K)

Multicentre, observational, retrospective cohort of hyperkalaemia burden at haemodialysis facility-level in China: the Visualize-HD study protocol

Association of Serum Potassium Levels with Mortality and Cardiovascular Events: Findings from the Chinese Multi-provincial Cohort Study

Prevalence and Prognosis of Hyperkalemia in Patients with Acute Myocardial Infarction